AB
TNXP icon

Amalgamated Bank’s Tonix Pharmaceuticals TNXP Stock Holding History

Amalgamated Bank’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-365
Closed -$6K – 2719
2025
Q4 		$6K Buy
365
+107
+41% +$1.97K ﹤0.01% 2678
2025
Q3 		$6K Hold
258
– – ﹤0.01% 2710
2025
Q2 		$9K Buy
+258
New +$6.76K ﹤0.01% 2508
2022
Q2 		– Hold
0
– -$12K – 3197
2022
Q1 		– Hold
0
– – – 2928
2021
Q4 		– Hold
0
– – – 2146
2021
Q3 		– Hold
0
– – – 2155
2021
Q2 		– Hold
0
– – – 2162

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Amalgamated Bank's TNXP Position: Q1 2026 in Review

Amalgamated Bank sold out of Tonix Pharmaceuticals (TNXP) in Q1 2026, closing a stake of 365 shares — an estimated $6K sold.

Amalgamated Bank first reported a position in TNXP in Q2 2025 and held it in 3 quarters. The position peaked at $9K in Q2 2025. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • Amalgamated Bank reported no remaining Tonix Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 365 Tonix Pharmaceuticals shares in Q1 2026, an estimated $6K.
  • Amalgamated Bank first reported a position in Tonix Pharmaceuticals in Q2 2025 and held it in 3 quarters.
  • Amalgamated Bank's Tonix Pharmaceuticals position peaked at $9K in Q2 2025.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.